Kaleyra, Inc. Warrants, each whole Warrant exercisable for one share of Common Stock at an exercise price of $40.25 per share
KLR.WS
KLR.WS was delisted on the 4th of October, 2023.
8 hedge funds and large institutions have $333K invested in Kaleyra, Inc. Warrants, each whole Warrant exercisable for one share of Common Stock at an exercise price of $40.25 per share in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 8 → 8 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
53% less capital invested
Capital invested by funds: $705K → $333K (-$372K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$6.47K |
| 2 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$23 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Capital
New York
|
-$30.9K |
| 2 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$13K |
| 3 |
PFM
Privium Fund Management
Amsterdam,
Netherlands
|
-$4K |
KLR.WS Hedge Fund Activity: Q3 2022 in Review
8 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Kaleyra, Inc. Warrants, each whole Warrant exercisable for one share of Common Stock at an exercise price of $40.25 per share (KLR.WS) for Q3 2022, worth a combined $333K — down 53% from $705K a quarter earlier.
Fund positioning in KLR.WS was balanced in Q3 2022: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 2 trimmed.
The largest buyer was Morgan Stanley, opening a new position worth an estimated $6.47K. The largest seller was Walleye Capital, cutting an estimated $30.9K.
- 8 institutional investors held Kaleyra, Inc. Warrants, each whole Warrant exercisable for one share of Common Stock at an exercise price of $40.25 per share (KLR.WS) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $333K of Kaleyra, Inc. Warrants, each whole Warrant exercisable for one share of Common Stock at an exercise price of $40.25 per share stock for Q3 2022, down 53% quarter-over-quarter.
- 1 fund opened new Kaleyra, Inc. Warrants, each whole Warrant exercisable for one share of Common Stock at an exercise price of $40.25 per share positions in Q3 2022 and 1 closed out, a net change of 0 holders.
- The largest Kaleyra, Inc. Warrants, each whole Warrant exercisable for one share of Common Stock at an exercise price of $40.25 per share buyer in Q3 2022 was Morgan Stanley, an estimated $6.47K added.
- The largest Kaleyra, Inc. Warrants, each whole Warrant exercisable for one share of Common Stock at an exercise price of $40.25 per share seller in Q3 2022 was Walleye Capital, an estimated $30.9K sold.
Based on aggregated 13F filings for Q3 2022.